Gilead Sciences
Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.
GILD Key Statistics
Stock Snapshot
The current Gilead Sciences(GILD) stock price is $156.50, with a market capitalization of 190.46B. The stock trades at a price-to-earnings (P/E) ratio of -57.80 and offers a dividend yield of 2.20%.
During the trading session on 2026-10-15, Gilead Sciences(GILD) shares reached a daily high of $156.50 and a low of $155.11. At a current price of $156.50, the stock is +0.9% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 12.66K, compared to an average daily volume of 5.18M.
Over the past 52 weeks, Gilead Sciences(GILD) stock has traded between a high of $157.29 and a low of $114.02.
Over the past 52 weeks, Gilead Sciences(GILD) stock has traded between a high of $157.29 and a low of $114.02.
GILD News
Vir Biotechnology Inc. (NASDAQ:VIR) announced a major collaboration with Gilead Sciences Inc. (NASDAQ:GILD) to create three novel T-cell engagers (TCEs) aimed a...
Vir Biotechnology (VIR) announced a collaboration and license agreement with Gilead (GILD) to discover and engineer three novel PRO-XTEN dual-masked T-cell enga...
...
Analyst ratings
77%
of 30 ratingsMore GILD News
If Gilead Sciences was on your watchlist instead of in your portfolio, the gap may feel a bit raw. For Gilead Sciences shareholders, the return over the past ye...
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of cou...
Gilead Sciences (GILD) moved back into focus after a strong quarterly report, with revenue growth topping analyst expectations and management lifting its HIV sa...
Gilead Sciences (GILD Quick QuoteGILD - Free Report) closed at $151.17 in the latest trading session, marking a +2.77% move from the prior day. The stock...
Gilead Sciences reported a strong Q2, with revenue up 10.2% year on year and full year EPS guidance above analyst estimates, and extended a five year DevOps and...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.